Live cell imaging was valued at $2.4 billion in 2025 and is projected to reach $4.9 billion by 2035, expanding at a CAGR of 7.5% during 2026–2035. Live cell imaging enables real-time visualization of cellular processes, playing a critical role in biological research, drug discovery, and disease diagnostics. The technology is widely used across applications such as cell biology, stem cell research, cancer research, and developmental biology, with strong adoption among pharmaceutical and biotechnology companies, academic institutes, CROs, and hospitals.

IT infrastructure management software Market was valued at $32.5 billion in 2025 and is projected to reach $93.0 billion by 2035, registering a CAGR of 11.2% during the forecast period from 2026 to 2035. Growth is being driven by increasing digitalization across pharmaceutical manufacturing, clinical research, and healthcare data ecosystems, where robust infrastructure monitoring and automation are essential. A key macro driver is the rapid expansion of global healthcare data and digital systems; according to the World Health Organisation, more than 50% of countries have adopted national digital health strategies, accelerating the shift toward cloud and hybrid IT environments. Among segments, AI/ML-enabled infrastructure management (AIOps) is the fastest growing, as it enables automated anomaly detection and predictive maintenance in complex healthcare IT systems. Pharmaceutical companies are increasingly leveraging AIOps to manage hybrid infrastructures and maintain regulatory compliance.

Infusion pump market is projected to grow from $8.7 billion in 2025 to $16.3 billion by 2035, registering a CAGR of 6.5% during the forecast period. The market growth is primarily driven by the increasing prevalence of chronic diseases, rising demand for precision drug delivery, and the expansion of home-based healthcare systems globally. A key macro driver accelerating market growth is the rising global burden of diabetes, which directly fuels demand for infusion pumps, particularly insulin pumps. According to the World Health Organization, approximately $422 million people globally are living with diabetes, with the majority residing in low- and middle-income countries. Additionally, the International Diabetes Federation estimates that this number could rise to $643 million by 2030, significantly increasing the need for continuous insulin delivery systems. This surge in patient population is directly translating into higher adoption of infusion pumps, especially in home care settings where automated and wearable devices are preferred.

Heparin market size was valued at $8.5 billion in 2025 and is projected to reach $12.1 billion by 2035, growing at a CAGR of 3.8% during 2026–2035. Growth in this market is primarily driven by the rising global burden of cardiovascular diseases and thrombotic disorders, which significantly increase the demand for anticoagulants such as heparin across hospitals and clinical settings.

Healthcare inventory management systems market was valued at $8.4 billion in 2025 and is projected to reach $20.2 billion by 2035, growing at a CAGR of 9.2% during the forecast period (2025–2035). These systems play a critical role in managing medical supplies, pharmaceuticals, and equipment across hospitals, clinics, and healthcare networks. By ensuring real-time tracking, reducing wastage, and optimizing procurement, healthcare inventory management solutions are becoming essential for improving operational efficiency and patient care outcomes. A key macro driver accelerating market growth is the increasing healthcare expenditure and patient volume globally. According to data from the World Health Organization (WHO), global health spending reached over $9 trillion, accounting for approximately 10% of global GDP. Additionally, the U.S. Centers for Medicare & Medicaid Services (CMS) reported that U.S. healthcare spending grew by 7.5% in 2023, reaching $4.9 trillion, with continued growth projected through 2030. This surge in spending is driving healthcare providers to adopt advanced inventory systems to minimize operational costs, reduce stockouts, and enhance supply chain resilience. As healthcare systems expand, the need for automated, data-driven inventory solutions continues to intensify.

Precious metals e-waste recovery market was valued at $9.2 billion in 2025 and is projected to reach $15.1 billion by 2035, growing at a CAGR of 5.2% during the forecast period (2026-2035). Robotic disassembly systems are emerging as a significant technological trend in the global precious metals e-waste recovery market. These systems are designed to improve the efficiency and precision of electronic waste processing while enabling higher recovery of valuable materials. Robotic disassembly systems utilize industrial robots equipped with sensors, artificial intelligence software, and specialized tools to dismantle electronic products such as computers, televisions, and smartphones. Unlike conventional shredding methods, these systems selectively remove key components including circuit boards, batteries, and connectors that contain precious metals such as gold and palladium. The process typically involves the identification of device components through AI-enabled vision systems and 3D cameras, followed by algorithm-based planning of the disassembly sequence. 

Fitness market was valued at $40.2 billion in 2025 and is projected to reach $80.5 billion by 2035, expanding at a CAGR of 7.2% during 2026–2035. The market growth is primarily driven by the rising prevalence of lifestyle-related diseases and increasing global awareness regarding physical fitness and preventive healthcare. Additional factors supporting market expansion include the growing adoption of digital fitness platforms and connected equipment, increasing investments in gym infrastructure and corporate wellness programs, and the rising demand for personalized and home-based fitness solutions. Technological advancements such as AI-enabled coaching, wearable integration, and real-time performance monitoring are further enhancing user engagement and accessibility. Moreover, urbanization and sedentary lifestyles are contributing to increased health risks, thereby encouraging individuals to adopt structured fitness routines.

Over The Top (OTT) Content market was valued at approximately $269.0 billion in 2025 and is projected to reach $585.8 billion by 2035, expanding at a CAGR of 8.2% during the forecast period (2026–2035). OTT content platforms include subscription-based (SVOD), ad-supported (AVOD), and transactional (TVOD) models delivering video, live streaming, and audio content directly to consumers. A key macro driver fueling this market is the global expansion of internet connectivity and mobile data usage. The rapid growth in global internet connectivity and smartphone adoption is a major driver for OTT platforms. ITU data confirms that increasing internet penetration is expanding the global digital audience, directly supporting higher consumption of streaming services across regions

Neurology devices market was valued at $18.9 billion in 2025 and is expected to grow to $37.5 billion by 2035, reflecting a CAGR of 7.2% over the forecast period (2026-2035). This growth is driven by rising prevalence of neurological disorders such as stroke, Parkinson’s disease, epilepsy, and Alzheimer’s, combined with increasing adoption of advanced neurotechnologies in hospitals and specialty clinics. According to the World Health Organization (WHO), approximately 15 million people worldwide suffer a stroke annually, with 5 million left permanently disabled, driving demand for neurosurgical and neurostimulation devices in acute and rehabilitative care. Among product types, Neurostimulation Devices are seeing the fastest adoption, driven by innovations in deep brain stimulation (DBS), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). These devices are increasingly used for epilepsy, Parkinson’s disease, and chronic pain, with the U.S. Food and Drug Administration (FDA) reporting more than 100,000 DBS implantations worldwide by 2024, indicating strong market traction.

Diagnostic imaging equipment market was valued at approximately $48.2 billion in 2025 and is projected to reach $83.4 billion by 2035, growing at a CAGR of 5.8% during 2026–2035. This growth is primarily driven by the rising burden of chronic diseases and the increasing demand for early and accurate diagnosis across healthcare systems globally. A key macro driver influencing market expansion is the growing prevalence of non-communicable diseases (NCDs). According to the World Health Organization (WHO), NCDs account for nearly 74% of all global deaths, with cardiovascular diseases alone responsible for 17.9 million deaths annually. Additionally, cancer cases are projected to rise significantly, with the International Agency for Research on Cancer (IARC) estimating over 35 million new cancer cases by 2050, up from 20 million in 2022. This surge directly increases the demand for imaging modalities such as CT, MRI, and PET scans for early detection, staging, and monitoring.